AKT1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.770000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.845600E-02
Normal-vs-Stage2
8.735200E-01
Normal-vs-Stage3
8.293400E-01
Normal-vs-Stage4
8.971000E-01
Stage1-vs-Stage2
5.877800E-02
Stage1-vs-Stage3
7.237400E-01
Stage1-vs-Stage4
1.781390E-01
Stage2-vs-Stage3
7.432800E-01
Stage2-vs-Stage4
9.931800E-01
Stage3-vs-Stage4
7.617800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.665800E-01
Normal-vs-AfricanAmerican
6.040600E-01
Normal-vs-Asian
8.681800E-01
Caucasian-vs-AfricanAmerican
3.705800E-01
Caucasian-vs-Asian
7.226600E-01
AfricanAmerican-vs-Asian
4.599400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.568400E-01
Normal-vs-Female
9.845400E-01
Male-vs-Female
8.918800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.651400E-01
Normal-vs-Age(41-60Yrs)
6.026200E-01
Normal-vs-Age(61-80Yrs)
9.290800E-01
Normal-vs-Age(81-100Yrs)
5.550200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.993800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.400000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.607200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.744200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.288400E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.625600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.042000E-01
Normal-vs-Daily Drinker
9.689000E-01
Normal-vs-Weekly Drinker
5.981400E-01
Normal-vs-Occasional Drinker
7.785000E-01
Normal-vs-Social Drinker
4.837800E-01
Non Drinker-vs-Daily Drinker
4.424200E-01
Non Drinker-vs-Weekly Drinker
9.242400E-02
Non Drinker-vs-Occasional Drinker
2.102200E-01
Non Drinker-vs-Social Drinker
6.339700E-02
Daily Drinker-vs-Weekly Drinker
2.593200E-01
Daily Drinker-vs-Occasional Drinker
5.891800E-01
Daily Drinker-vs-Social Drinker
1.994760E-01
Weekly Drinker-vs-Occasional Drinker
4.521400E-01
Weekly Drinker-vs-Social Drinker
9.756200E-01
Occasional Drinker-vs-Social Drinker
3.775600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.049800E-01
Normal-vs-Grade 2
6.825800E-01
Normal-vs-Grade 3
6.983400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.827640E-02
Grade 1-vs-Grade 3
6.554500E-02
Grade 1-vs-Grade 4
8.049800E-01
Grade 2-vs-Grade 3
6.841800E-01
Grade 2-vs-Grade 4
6.825800E-01
Grade 3-vs-Grade 4
6.983400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.176800E-01
Normal-vs-NonDiabetic
8.541600E-01
Diabetic-vs-NonDiabetic
9.423500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.637600E-01
Normal-vs-NoPancreatitis
9.849200E-01
Pancreatitis-vs-NoPancreatitis
9.570200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.715800E-01
Normal-vs-N1
8.835600E-01
N0-vs-N1
1.565400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.147400E-01
Normal-vs-TP53-NonMutant
5.262400E-01
TP53-Mutant-vs-TP53-NonMutant
1.974110E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
